4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-20-000120
CIK 0001615219other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:02 PM ET
Size
5.4 KB
Accession
0001615219-20-000120
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2020-12-02+80,000→ 80,000 totalExercise: $0.74Exp: 2030-12-01→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]25% of the options are fully vested on December 1, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:02 PM ET
- Size
- 5.4 KB